Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$31.03
+13.3%		$32.17
$13.74
▼
$65.30
$6.39B2.415.33 million shs19.94 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-3.77%-11.33%-16.62%+18.93%-39.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$31.03
+13.3%		$32.17
$13.74
▼
$65.30
$6.39B2.415.33 million shs19.94 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-3.77%-11.33%-16.62%+18.93%-39.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.19
Hold$32.434.53% Upside

Current Analyst Ratings Breakdown

Latest HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $26.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $30.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$21.00 ➝ $28.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$35.00 ➝ $33.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$30.00 ➝ $32.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$35.00 ➝ $42.00
8/7/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
7/24/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$23.00 ➝ $27.00
7/23/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$28.00 ➝ $35.00
7/13/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B3.08$0.95 per share32.73$1.39 per share22.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A62.06N/A-5.51%-6.51%-1.20%11/2/2026 (Estimated)

Latest HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.21
0.93
0.87

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million205.88 millionOptionable

Recent News About These Companies

Kaplan Fox is Investigating Hims & Hers Health, Inc. (HIMS) on Behalf of Investors for Potential Securities Law Violations
August 19 at 2:45 PM  |  newsfilecorp.comN
Hims & Hers Health (NYSE:HIMS) Stock Price Up 10.8% - What's Next?
August 19 at 2:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hims-hers-health-nysehims-stock-price-up-108-whats-next-2026-08-19/
Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access
August 19 at 12:32 PM  |  benzinga.comhttps://www.benzinga.com/news/health-care/26/08/61308380/hims-hers-rejects-privacy-allegations-while-promising-expanded-patient-access?utm_source=snapi
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)
August 19 at 9:06 AM  |  newsfilecorp.comN
Hims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 9,388 Shares of Stock
August 19 at 6:06 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-hims-insider-buying-and-selling-2026-08-19/
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know.
August 19 at 6:00 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/hims-and-hers-ceo-just-disposed-of-78-859-shares-here-s-what-long-term-investors-should-know/
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means
August 19 at 6:00 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/the-cto-of-hims-and-hers-just-gave-up-nearly-usd2-7-million-in-stock-here-s-what-it-actually-means/
An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know
August 19 at 6:00 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/an-insider-at-hims-and-hers-disposed-of-over-usd3-million-in-stock-here-s-what-long-term-investors-should-know/
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip
August 19 at 6:00 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/an-insider-at-hims-and-hers-just-filed-here-s-what-it-says-about-buying-the-dip/
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows
August 19 at 5:37 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/hims-and-hers-chief-accounting-officer-is-leaving-here-s-what-her-latest-insider-filing-shows/
What Long-Term Investors Should Know About This Hims Insider Filing
August 19 at 5:21 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/what-long-term-investors-should-know-about-this-hims-insider-filing/
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know
August 19 at 5:11 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/a-hims-and-hers-insider-disposed-of-stock-as-the-company-pushes-into-testosterone-and-peptides-here-s-what-to-know/
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.
August 19 at 5:03 AM  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/19/hims-and-hers-policy-chief-just-filed-an-insider-transaction-here-s-what-it-means/
Hims & Hers CEO Andrew Dudum says AI health coach could be just 12 months away, believes it could increase medication adherence
August 18 at 10:19 PM  |  msn.comhttps://www.msn.com/en-in/news/other/hims-hers-ceo-andrew-dudum-says-ai-health-coach-could-be-just-12-months-away-believes-it-could-increase-medication-adherence/ar-AA2aoOcW
Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?
August 18 at 10:19 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/why-hims-hers-health-hims-231618995.html
Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
August 18 at 7:55 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/kessler-topaz-meltzer--check-llp-encourages-hims--hers-health-inc-nyse-hims-investors-to-contact-the-firm-302854598.html
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells $261,831.32 in Stock
August 18 at 7:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-hims-hers-health-nysehims-cfo-sells-26183132-in-stock-2026-08-18/
Oluyemi Okupe Sells 55,383 Shares of Hims & Hers Health (NYSE:HIMS) Stock
August 18 at 7:06 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/oluyemi-okupe-sells-55383-shares-of-hims-hers-health-nysehims-stock-2026-08-18/
Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
August 18 at 6:07 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3347341/32716/en/hims-hers-health-nyse-hims-stock-plunges-14-following-major-ftc-lawsuit-over-privacy-billing-hagens-berman-investigates-corporate-compliance-and-investor-ramifications.html
Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum
August 18 at 1:00 PM  |  youtube.comY
Hims & Hers CEO says FTC lawsuit misunderstands how the company works
August 18 at 10:20 AM  |  cnbc.comhttps://www.cnbc.com/2026/08/18/hims-hers-ceo-andrew-dudum-ftc-lawsuit-glp-1s-ai.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Hims & Hers Health logo with a two-toned teal and coral capsule pill on a matching gradient background.
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic
By Jessica Mitacek | August 5, 2026
Bear statue on a trading desk surrounded by red downward stock charts on multiple monitors in a trading floor.
Bearish Pressure Is Building Around These 3 Stocks
By Jessica Mitacek | August 3, 2026
Hims & Hers Health branded product packaging displayed on a table, including bottles labeled "hims" and "hers".
Hims & Hers’ Revenue Beat Came With a Profitability Problem
By Jessica Mitacek | August 12, 2026
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$31.03 +3.64 (+13.29%)
Closing price 03:59 PM Eastern
Extended Trading
$30.76 -0.27 (-0.87%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas